CVRx, Inc.
CVRXNASDAQHealthcare● Active
$5.40
+$0.02(+0.37%)
Market Cap$143293860
P/E Ratio—
52W High$11.3
52W Low$4.37
CVRx, Inc. (CVRX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CVRX · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 11, 2026EPS Actual
-$0.50
Est. -$0.51 · +2.0%
Revenue
$0.01B
Est. $0.01B · +1.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 11, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
CVRX reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | -$0.52 | — | — | — | $0.02B | — |
| ▲ Q2 FY2026 | May 11, 2026 | -$0.51 | -$0.50 | +2.0% | $0.01B | $0.01B | +1.9% |
| ▼ Q1 FY2026 | Feb 12, 2026 | -$0.42 | -$0.46 | -9.5% | $0.02B | $0.02B | +1.6% |
| ▲ Q4 FY2025 | Nov 5, 2025 | -$0.50 | -$0.49 | +2.0% | $0.01B | $0.02B | -6.7% |
| ▼ Q3 FY2025 | Aug 4, 2025 | -$0.52 | -$0.57 | -9.6% | $0.01B | $0.01B | -5.6% |
| ▲ Q2 FY2025 | May 8, 2025 | -$0.56 | -$0.53 | +5.4% | $0.01B | $0.01B | -7.3% |
| ▼ Q1 FY2025 | Feb 4, 2025 | -$0.37 | -$0.43 | -16.2% | $0.02B | $0.02B | +0.8% |
| ▼ Q4 FY2024 | Oct 29, 2024 | -$0.45 | -$0.57 | -26.7% | $0.01B | $0.01B | +1.2% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
-$0.52
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 11, 2026Beat
EPS Actual
-$0.50
EPS Est.
-$0.51
EPS Surpr.
+2.0%
Revenue
$0.01B
Q1 FY2026
Feb 12, 2026Miss
EPS Actual
-$0.46
EPS Est.
-$0.42
EPS Surpr.
-9.5%
Revenue
$0.02B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
-$0.49
EPS Est.
-$0.50
EPS Surpr.
+2.0%
Revenue
$0.01B
Q3 FY2025
Aug 4, 2025Miss
EPS Actual
-$0.57
EPS Est.
-$0.52
EPS Surpr.
-9.6%
Revenue
$0.01B
Q2 FY2025
May 8, 2025Beat
EPS Actual
-$0.53
EPS Est.
-$0.56
EPS Surpr.
+5.4%
Revenue
$0.01B
Q1 FY2025
Feb 4, 2025Miss
EPS Actual
-$0.43
EPS Est.
-$0.37
EPS Surpr.
-16.2%
Revenue
$0.02B
Q4 FY2024
Oct 29, 2024Miss
EPS Actual
-$0.57
EPS Est.
-$0.45
EPS Surpr.
-26.7%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $-0.43 | $-0.42 | $-0.41 | 2 |
| Q3 FY2028 | $-0.47 | $-0.46 | $-0.45 | 2 |
| Q2 FY2028 | $-0.50 | $-0.49 | $-0.48 | 2 |
| Q1 FY2028 | $-0.54 | $-0.53 | $-0.52 | 2 |
| Q4 FY2027 | $-0.44 | $-0.43 | $-0.42 | 1 |
| Q3 FY2027 | $-0.45 | $-0.44 | $-0.43 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 11, 2026 | +2.0% | $6.83 | $6.92 | +1.32% |
| ▼ Q1 FY2026 | Feb 12, 2026 | -9.5% | $6.08 | $5.69 | -6.41% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +2.0% | $9.99 | $9.79 | -2.00% |
| ▼ Q3 FY2025 | Aug 4, 2025 | -9.6% | $7.56 | $7.55 | -0.13% |
| ▲ Q2 FY2025 | May 8, 2025 | +5.4% | $7.48 | $7.78 | +4.01% |
| ▼ Q1 FY2025 | Feb 4, 2025 | -16.2% | $15.46 | $16.25 | +5.11% |
| ▼ Q4 FY2024 | Oct 29, 2024 | -26.7% | $10.29 | $10.74 | +4.37% |
| ▼ Q3 FY2024 | Jul 29, 2024 | -27.4% | $9.61 | $9.27 | -3.54% |
Q2 FY2026+1.32%
Report Date
May 11, 2026
EPS Beat/Miss
+2.0%
Price Before
$6.83
Price After
$6.92
Q1 FY2026-6.41%
Report Date
Feb 12, 2026
EPS Beat/Miss
-9.5%
Price Before
$6.08
Price After
$5.69
Q4 FY2025-2.00%
Report Date
Nov 5, 2025
EPS Beat/Miss
+2.0%
Price Before
$9.99
Price After
$9.79
Q3 FY2025-0.13%
Report Date
Aug 4, 2025
EPS Beat/Miss
-9.6%
Price Before
$7.56
Price After
$7.55
Q2 FY2025+4.01%
Report Date
May 8, 2025
EPS Beat/Miss
+5.4%
Price Before
$7.48
Price After
$7.78
Q1 FY2025+5.11%
Report Date
Feb 4, 2025
EPS Beat/Miss
-16.2%
Price Before
$15.46
Price After
$16.25
Q4 FY2024+4.37%
Report Date
Oct 29, 2024
EPS Beat/Miss
-26.7%
Price Before
$10.29
Price After
$10.74
Q3 FY2024-3.54%
Report Date
Jul 29, 2024
EPS Beat/Miss
-27.4%
Price Before
$9.61
Price After
$9.27
Avg Beat Reaction+1.11%
Avg Miss Reaction-0.12%
Beat Rate3 / 8 quarters
Largest Move-6.41% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CVRX ends December
CVRx, Inc. (CVRX) most recently reported earnings on May 11, 2026 for Q2 FY2026, posting EPS of $-0.50 — beating the analyst consensus of $-0.51 by +2.0%. The next CVRX earnings date is expected around September 1, 2026.
Each quarter, investors track CVRX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CVRX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CVRX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CVRX earnings · 5 questionsCVRx, Inc.'s next earnings report is expected around September 1, 2026. CVRX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CVRX historically reports after market close (AMC).
CVRX earnings datewhen is CVRX earningsCVRX next earnings datewhen does CVRX report earningsCVRX earnings calendar
▸ Source: FMP · CVRx, Inc. SEC filings · US GAAP · CVRx, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026